248 related articles for article (PubMed ID: 38450182)
1. LINC01134: a pivotal oncogene with promising predictive maker and therapeutic target in hepatocellular carcinoma.
Yu Y; Wang J; Guo Q; Luo H
Front Oncol; 2024; 14():1265762. PubMed ID: 38450182
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-κB Signaling.
Wang C; Chen Y; Chen K; Zhang L
Front Cell Dev Biol; 2020; 8():429. PubMed ID: 32656205
[TBL] [Abstract][Full Text] [Related]
3. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
Rong Z; Wang Z; Wang X; Qin C; Geng W
J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
[TBL] [Abstract][Full Text] [Related]
4. Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1.
Zheng S; Guo Y; Dai L; Liang Z; Yang Q; Yi S
Bioengineered; 2020 Dec; 11(1):1016-1026. PubMed ID: 32970959
[TBL] [Abstract][Full Text] [Related]
5. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC01134 Contributes to Radioresistance in Hepatocellular Carcinoma by Regulating DNA Damage Response
Wang Z; Wang X; Rong Z; Dai L; Qin C; Wang S; Geng W
Front Pharmacol; 2021; 12():791889. PubMed ID: 35173610
[TBL] [Abstract][Full Text] [Related]
7. Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma.
Kang X; Huo Y; Jia S; He F; Li H; Zhou Q; Chang N; Liu D; Li R; Hu Y; Zhang P; Xu A
Front Oncol; 2022; 12():939605. PubMed ID: 35875091
[TBL] [Abstract][Full Text] [Related]
8. The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine.
Li D; Fan X; Li Y; Yang J; Lin H
Genes Dis; 2022 Mar; 9(2):358-369. PubMed ID: 35224152
[TBL] [Abstract][Full Text] [Related]
9. Integrated RNA Sequencing and Single-Cell Mass Cytometry Reveal a Novel Role of LncRNA HOXA-AS2 in Tumorigenesis and Stemness of Hepatocellular Carcinoma.
Lu Q; Gao J; Tang S; Li Z; Wang X; Deng C; Hu J; Tao Y; Wang Q
Onco Targets Ther; 2020; 13():10901-10916. PubMed ID: 33149607
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets.
Hashemi M; Mirzaei S; Zandieh MA; Rezaei S; Amirabbas Kakavand ; Dehghanpour A; Esmaeili N; Ghahremanzade A; Saebfar H; Heidari H; Salimimoghadam S; Taheriazam A; Entezari M; Ahn KS
Prog Biophys Mol Biol; 2023 Jan; 177():207-228. PubMed ID: 36584761
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC.
Li X; Zhang Z; Liu M; Fu X; A J; Chen G; Wu S; Dong JT
Front Immunol; 2022; 13():880288. PubMed ID: 35572559
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
Wong LS; Wei L; Wang G; Law CT; Tsang FH; Chin WC; Ng IO; Wong CM
Cell Mol Gastroenterol Hepatol; 2022; 14(5):1053-1076. PubMed ID: 35944892
[TBL] [Abstract][Full Text] [Related]
13. The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective.
Unfried JP; Sangro P; Prats-Mari L; Sangro B; Fortes P
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071216
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
15. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
[TBL] [Abstract][Full Text] [Related]
16. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials.
Khan A; Zhang X
Bioengineering (Basel); 2022 Aug; 9(8):. PubMed ID: 36004931
[TBL] [Abstract][Full Text] [Related]
17. Molecular pattern of lncRNAs in hepatocellular carcinoma.
Mai H; Zhou B; Liu L; Yang F; Conran C; Ji Y; Hou J; Jiang D
J Exp Clin Cancer Res; 2019 May; 38(1):198. PubMed ID: 31097003
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma.
Wu Y; Zhang Y; Qin X; Geng H; Zuo D; Zhao Q
Pharmacol Res; 2020 Oct; 160():105195. PubMed ID: 32916254
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
